Format

Send to

Choose Destination
Clin Microbiol Infect. 2017 Feb;23(2):58-60. doi: 10.1016/j.cmi.2016.07.003. Epub 2016 Jul 9.

The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.

Author information

1
'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy.
2
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
3
Laboratoire INSERM Jean Mérieux, Lyon, France.
4
Institute of Virology, University of Marburg, Marburg, Germany.
5
Public Health England, Porton Down, Salisbury, UK.
6
SMI, Solna, Sweden.
7
Instituto Nacional de Saude, Lisbon, Portugal.
8
Centro Nacional de Microbiologia, ISCIII, Madrid, Spain.
9
National Center for Epidemiology, Budapest, Hungary.
10
Bundeswehr Institute of Microbiology, Munich, Germany.
11
Robert Koch Institut, Berlin, Germany.
12
Federal Office for Civil Protection, Spiez Laboratory, Switzerland.
13
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
14
European Commission, DG SANTE, Health Threats Unit, Luxembourg.
15
European Commission, Consumers, Health, Agriculture and Food Executive Agency (CHAFEA), Luxembourg.
16
'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy. Electronic address: antonino.dicaro@inmi.it.

KEYWORDS:

BSL-4; Biosafety; Ebola virus disease; Emerging diseases; High containment laboratories; Laboratory networks

PMID:
27404371
DOI:
10.1016/j.cmi.2016.07.003
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center